Grand Pharma Sustainability Profile
Grand Pharma (also known as Grand Pharmaceutical Group Limited) is a prominent player in the pharmaceutical industry, headquartered in China (CN). Established in 1998, the company has made significant strides in the development, manufacturing, and distribution of innovative healthcare solutions across various operational regions, including Asia and beyond. Specialising in prescription drugs, over-the-counter medications, and active pharmaceutical ingredients, Grand Pharma distinguishes itself through its commitment to quality and research-driven approaches. The company has achieved notable milestones, including strategic partnerships and a robust portfolio of unique products that cater to diverse therapeutic areas. With a strong market position, Grand Pharma is recognised for its contributions to healthcare, consistently striving to enhance patient outcomes and expand its global footprint.
DitchCarbon Score
How does Grand Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Grand Pharma's score of 16 is lower than 90% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Grand Pharma's reported carbon emissions
In 2021, Grand Pharma reported total emissions of approximately 276 million kg CO2e, comprising about 172 million kg CO2e from Scope 1 and about 104 million kg CO2e from Scope 2 emissions. There is no available data for Scope 3 emissions. As a current subsidiary of Grand Pharmaceutical (China) Co., Ltd., the emissions data is cascaded from this parent organization. However, there are no specific reduction targets or climate pledges disclosed in the available information. Grand Pharma's commitment to addressing climate change is reflected in its participation in various sustainability initiatives, although specific targets or achievements have not been outlined. The company continues to monitor and report its emissions as part of its broader environmental strategy.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | |
|---|---|
| Scope 1 | 172,000,000 |
| Scope 2 | 104,000,000 |
| Scope 3 | - |
How Carbon Intensive is Grand Pharma's Industry?
How Carbon Intensive is Grand Pharma's Location?
Grand Pharma's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Grand Pharma has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
